论文部分内容阅读
为规范非酒精性脂肪性肝病(NAFLD)的诊治与疗效评估,中华医学会肝病学分会脂肪肝和酒精性肝病学组按照循证医学的原则,于2006年5月制定了《非酒精性脂肪性肝病诊疗指南》。与国际上发表的指南或共识相比,较为全面和广泛地反映了目前NAFLD的临床诊疗现状,尽管彼此类似,但在诊治规范上也存在差异,本文就国内外NAFLD诊疗指南的异同进行解读。
In order to regulate the diagnosis and treatment of non-alcoholic fatty liver disease (NAFLD) and assess the efficacy, the Chinese Medical Association of Liver Diseases credits fatty liver and alcoholic liver disease group according to the principle of evidence-based medicine, in May 2006 developed a “non-alcoholic fats Sexual liver disease diagnosis and treatment guidelines. ” Compared with the published guidelines or consensus in the world, the status quo of clinical diagnosis and treatment of NAFLD is relatively comprehensive and extensively reflected. Although they are similar to each other, there are also differences in the standard of diagnosis and treatment. The similarities and differences of NAFLD treatment guidelines at home and abroad are interpreted in this paper.